Degenerative Disc Disease
-
Comparison of Two-Level versus One-Level Total Disc Replacement: Results from a Prospective FDA-Regulated Trial
August 2008
Jack E. Zigler, Donna D. Ohnmeiss
-
The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment
January 2008
Scott L. Blumenthal, Richard D. Guyer, F. Geisler, Paul C. McAfee, J. Regan
-
Two- to Three-Year Follow-Up of ProDisc-L: Results from a Prospective Randomized Trial of Arthroplasty versus Fusion
October 2007
Jack E. Zigler, Barton L. Sachs, Ralph F. Rashbaum, Donna D. Ohnmeiss
-
An Economic Model of One-Level Lumbar Arthroplasty versus Fusion
October 2007
Richard D. Guyer, Scott G. Tromanhauser, John J. Regan
-
Complications of Lumbar Artificial Disc Replacement Compared to Fusion: Results from the Prospective, Randomized, Multicenter U.S. Food and Drug Administration Investigational Device Exemption Study of the Charité Artificial Disc
April 2007
R. T. Holt, M. E. Majd, J. E. Isaza, Scott L. Blumenthal, Paul C. McAfee, Richard D. Guyer, et al.
-
Lumbar Spine Arthroplasty Using the ProDisc II
November 2004
Jack E. Zigler
